Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction

Clinical Biochemistry

Volumn 46, Issue 1-2, 2013, Pages 26-30

  Lippi, Giuseppe ^a   Mattiuzzi, Camilla ^b   Cervellin, Gianfranco ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b Ospedale di Trento   (Italy)

Author keywords

H FABP; Heart type fatty acid binding protein; Ischemic heart disease; Myocardial infarction; Troponin

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; TROPONIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; AREA UNDER THE CURVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; META ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

AREA UNDER CURVE; EARLY DIAGNOSIS; FATTY ACID-BINDING PROTEINS; HUMANS; IMMUNOASSAY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84871738710     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.10.016     Document Type: Review

References (34)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:188-197.
2. Luepker R.V., Berger A.K. Is acute myocardial infarction disappearing?. Circulation 2010, 121:1280-1282.
3. McCarthy M.L. Overcrowding in emergency departments and adverse outcomes. BMJ 2011, 342:d2830.
4. Lippi G., Guidi G.C. The power of negative thinking. Am J Emerg Med 2008, 26:373-374.
5. Kavsak P.A., Allen L.C., Apple F.S., Booth R.A., Chan P.C., Delvin E., et al. Cardiac troponin testing in the acute care setting: ordering, reporting, and high sensitivity assays-an update from the Canadian society of clinical chemists (CSCC). Clin Biochem 2011, 44:1273-1277.
6. Lippi G., Cervellin G., Plebani M. Sensitive cardiac troponin T assay. N Engl J Med 2010, 362:1242.
7. Keller T., Zeller T., Peetz D., Tzikas S., Roth A., Czyz E., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
8. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
9. Lippi G., Cervellin G. Degradation of troponin I in serum or plasma: mechanisms, and analytical and clinical implications. Semin Thromb Hemost 2012, 38:222-229.
10. Storch J., Thumser A.E. Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem 2010, 285:32679-32683.
11. Glatz J.F., van Bilsen M., Paulussen R.J., Veerkamp J.H., Van Der Vusse G.J., Reneman R.S. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988, 961:148-152.
12. Tanaka T., Hirota Y., Sohmiya K., Nishimura S., Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991, 24:195-201.
13. Kleine A.H., Glatz J.F., Van Nieuwenhoven F.A., Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992, 116:155-162.
14. Bruins Slot M.H., Reitsma J.B., Rutten F.H., Hoes A.W., Van Der Heijden G.J. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis. Heart 2010, 96:1957-1963.
15. Viswanathan K., Hall A.S., Barth J.H. An evidence-based approach to the assessment of heart-type fatty acid binding protein in acute coronary syndrome. Clin Biochem Rev 2012, 33:3-11.
16. Carroll C., Al Khalaf M., Stevens J.W., Leaviss J., Goodacre S., Collinson P.O., et al. Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis. Emerg Med J May 16 2012, [Epub ahead of print].
17. Lippi G., Favalor E.J., Simundic A.M. Biomedical research platforms and their influence on article submissions and journal rankings: an update. Biochem Med (Zagreb) 2012, 22(1):7-14.
18. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
19. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation 2007, 116(22):2634-2653.
20. McCann C.J., Glover B.M., Menown I.B., Moore M.J., McEneny J., Owens C.G., et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008, 29:2843-2850.
21. Haltern G., Peiniger S., Bufe A., Reiss G., Gülker H., Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 2010, 105:1-9.
22. Xu Q., Chan C.P., Cao X.Y., Peng P., Mahemuti M., Sun Q., et al. Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction. Clin Chim Acta 2010, 411:1781-1787.
23. Li C.J., Li J.Q., Liang X.F., Li X.X., Cui J.G., Yang Z.J., et al. Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010, 31:307-312.
24. Liang Y., Chan C.P., Cheung K.Y., Cautherley G.W., Glatz J.F., Renneberg R., et al. CardioDetect rapid test for the diagnosis of early acute myocardial infarction. J Immunoassay Immunochem 2011, 32:342-352.
25. Hisamuddin Nar N., Suhailan M.A. Evaluation of the diagnostic indices and clinical utility of qualitative cardiodetect® test kit in diagnosis of ami within 12 hours of onset of chest pain in the emergency department. Int J Emerg Med 2011, 27(4):67.
26. McMahon C.G., Lamont J.V., Curtin E., McConnell R.I., Crockard M., Kurth M.J., et al. Diagnostic accuracy of heart-type fatty acid-binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med 2012, 30:267-274.
27. Freund Y., Chenevier-Gobeaux C., Leumani F., Claessens Y.E., Allo J.C., Doumenc B., et al. Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED. Am J Emerg Med Dec 2012, 30(8):1378-1384.
28. Liao J., Chan C.P., Cheung Y.C., Lu J.H., Luo Y., Cautherley G.W., et al. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 2009, 133(3):420-423.
29. Lippi G., Montagnana M., Salvagno G.L., Guidi G.C. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006, 8:27-31.
30. Chan D., Ng L.L. Biomarkers in acute myocardial infarction. BMC Med 2010, 8:34.
31. Glatz J.F., Van Der Vusse G.J., Simoons M.L., Kragten J.A., van Dieijen-Visser M.P., Hermens W.T. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998, 272:87-92.
32. Servonnet A., Delacour H., Dehan C., Gardet V. Heart fatty-acid binding protein (h-FABP): a new cardiac marker. Ann Biol Clin (Paris) 2006, 64:209-217.
33. Apple F.S., Ler R., Murakami M.M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem Sep 14 2012, [Epub ahead of print].
34. Kavsak P.A., Jaffe A.S. High-sensitivity cardiac troponin assays-change is important. Clin Chem 2012, 58:311-313.